Abstract
Although chemotherapy is indispensable for the treatment of ovarian cancer, secondary acute leukemia has become increasingly important as one of the most unfavorable late effects according to widespread long-term chemotherapy. We report a patient suffering from acute nonlymphocytic leukemia (ANLL) 3 years after treatment for stage IV ovarian cancer began.
Similar content being viewed by others
Author information
Authors and Affiliations
Additional information
Received: April 1999 / Accepted: 22 September 1999
Rights and permissions
About this article
Cite this article
Yokoyama, Y., Futagami, M., Fukushi, Y. et al. Secondary acute nonlymphocytic leukemia following successful chemotherapy combining cisplatin, doxorubicin, and cyclophosphamide for stage IV epithelial ovarian cancer. Arch Gynecol Obstet 263, 206–207 (2000). https://doi.org/10.1007/s004040050285
Issue Date:
DOI: https://doi.org/10.1007/s004040050285